Canada House to restructure business, aims to launch new retail arm

Reformation of the Canada House businesses aims to ensure efficient delivery of valuable cannabis, along with utmost care to recreational and medical cannabis consumers

Canada House Wellness Group Inc., an integrated medical cannabis company, has reportedly announced a significant restructuring of its business, aiming at future rebranding to distinguish and highlight its products and services. The company’s initiative is based on its aim to build on the sales license it was recently awarded.

Sources with the knowledge of the matter revealed another strategy of the company of aligning its businesses under three distinct verticals including its new retail division CHR (Canada House Retail), CHG (Canada House Grow) and CHC (Canada House Clinics). Each of the divisions clearly conveys its competitive market offering and is expected to deliver Quality Care as well as Quality Cannabis throughout all touchpoints, further cited sources.

Canada House, for the record, is an experienced cannabis company offering patient-specific cannabinoid therapy services and products via its authorized producer and different clinics. It is the parent company of Knalysis Technologies, Abba Medix Corp. and Canada House Clinics Inc.

Canada House CEO, Chris Churchill-Smith, was quoted saying that the company’s newly-developed brand shows its commitment towards providing the top Cannabinoid Therapy services, industry-leading production practices and will now provide a definite strategy for the robust recreational & adult use Canadian market through its CHR vertical.

He added that CHR is expected to house the Edmonton Dispensary initially and will take product development to another level by supervising sales and marketing efforts of genetics, seeds and the dried flower.

It has also been reported that the CHC, through its independent cannabis clinics, will focus on renewing the lives of patients with cannabinoid therapy awareness and patient-specific treatment protocols. On the other side, Knalysis will strive to improve on treatment effectiveness with its cannabis patient management software & data analytics.

Industry experts say that Canada House is immensely excited to launch its new retail segment, CHR, to purportedly market craft cannabis produced by CHG to the adult use market in Canada.